February 15, 2021
Article
Pfizer's drug product is the first FDA-approved intravenous immunoglobulin with 2 maintenance dosing options for CIDP.
December 17, 2020
Early experiments through the 19th century theorized local injection with human rabies immunoglobulin at the wound site provided better effects at neutralizing the virus.
December 15, 2020
If IVIG is commenced within 2 weeks from the onset of Guillain-Barre syndrome it can hasten recovery as much as plasma exchange, study indicates.
December 08, 2020
Intravenous immunoglobulin administered to hypoxic non-ventilated COVID-19 patients with an A-a gradient of more than 200 mg Hg significantly decreases the rates of progression to mechanical ventilation.
December 03, 2020
Researchers find no clear therapeutic benefit of intravenous immunoglobulin for the prevention of postnatal relapses of multiple sclerosis.
December 02, 2020
Xolair provides an alternative to surgery or steroids for the treatment of nasal polyps in adults.
November 19, 2020
The findings show that vaping changes the expression of genes and production of proteins in respiratory cells, as well as altering virus-specific antibody production, according to the study.
November 13, 2020
Although a single IVIG dose of 25 g was effective in most cases, for some strains repeated doses were necessary to achieve a significant reduction in superantigenic responses.
November 06, 2020
The availability of both intravenous and subcutaneous routes of immunoglobulin has made personalization of treatment more important than ever.
October 27, 2020
Both intravenous immunoglobulin and subcutaneous immunoglobulin are effective in treating myasthenia gravis.
